Norges Bank’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-54,900
| Closed | -$2.03M | – | 2169 |
|
|
2022
Q3 | $2.03M | Sell |
54,900
-1,800
| -3% | -$66.6K | ﹤0.01% | 1912 |
|
|
2022
Q2 | $1.08M | Buy |
+56,700
| New | +$1.08M | ﹤0.01% | 1957 |
|
|
2022
Q1 | – | Sell |
-98,500
| Closed | -$2.22M | – | 2222 |
|
|
2021
Q4 | $2.22M | Hold |
98,500
| – | – | ﹤0.01% | 2022 |
|
|
2021
Q3 | $2.58M | Buy |
+98,500
| New | +$2.58M | ﹤0.01% | 2011 |
|